Case series: Tumefactive demyelinating lesions: A diagnostic challenge

Canadian Journal of Surgery

Volumn 53, Issue 1, 2010, Pages 69-70

  Fallah, Aria ^a   Banglawala, Sarfaraz ^b   Ebrahim, Shanil ^a   Paulseth, John E ^c   Jha, Neilank K ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c Divisions of Neurology ^*

Author keywords

[No Author keywords available]

Indexed keywords

EID: 75749096002     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Given CA 2nd, Stevens BS, Lee C. The MRI appearance of tumefactive demyelinating lesions. AJR Am. J Roentgenol 2004; 182:195-199
2. Tan HM, Chan LL, Chuah KL, et al. Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropadiological diagnosis. Br J Radiol 2004;77:151-156
3. Mao-Draayer Y, Braff S, Pendlebury W, et al. Treatment of steroidunresponsive tumefactive demyelinating disease with plasma exchange. Neurology 2002;59:1074-1077
4. 4. Saindane AM, Cha S, Law M, et al. Proton MR spectroscopy of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 2002;23: 1378-1386 (Pubitemid 35033889)
5. 5. Cha S, Pierce S, Knopp EA, et al. Dynamic contrast-enhanced T2* weighted MR imaging of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 2001;22:1109-1116 (Pubitemid 32587424)